- Home
- Cancer Therapies Global Market Opportunities
Cancer Therapies Global Market Opportunities
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Cryo-Save Group N.V. (Symbol:CRYO) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2012
- 31 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Cryo-Save Group N.V. SWOT Analysis report provides you a strategic ...
Industries: Biological Therapy | Countries: Europe, South Africa, World, Africa, Netherlands
Cetuximab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Europe, World
Imiquimod - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Europe, World
Bevacizumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Europe, World
Epoetin alfa - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Europe, World
Trastuzumab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Europe, World
Trastuzumab - Key patent, SPC, and data exclusivity expiry (7 country coverage)
- $ 568
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Australia, United States, United Kingdom, World, Europe, Canada
Epoetin alfa - Key patent, SPC, and data exclusivity expiry (7 country coverage)
- $ 568
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Australia, United States, United Kingdom, World, Europe, Canada
Filgrastim - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Europe, World
Rituximab - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Biological Therapy | Countries: Europe, World
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- 00 1 718 618 48 97
Reportlinker.com © Copyright 2012. All rights reserved
